Pages that link to "Q51971140"
Jump to navigation
Jump to search
The following pages link to Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter? (Q51971140):
Displaying 50 items.
- Imaging small vessel-associated white matter changes in aging (Q30710587) (← links)
- White matter hyperintensities, cognitive impairment and dementia: an update (Q30893715) (← links)
- Role of cognitive enhancer therapy in Alzheimer's disease with concomitant cerebral white matter disease: findings from a long-term naturalistic study (Q34130449) (← links)
- Subcortical hyperintensity volumetrics in Alzheimer's disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory (Q34629862) (← links)
- Brain hypoperfusion: a critical factor in vascular dementia (Q35841696) (← links)
- Vascular dementia. Stroke risk and sequelae define therapeutic approaches (Q36021042) (← links)
- Cholinergic dysfunction in vascular dementia (Q36046170) (← links)
- Associations between a neurophysiological marker of central cholinergic activity and cognitive functions in young and older adults (Q36048738) (← links)
- Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions. (Q36109150) (← links)
- Anterior-medial thalamic lesions in dementia: frequent, and volume dependently associated with sudden cognitive decline (Q36142008) (← links)
- Rivastigmine for subcortical vascular dementia (Q36153360) (← links)
- Dementia with cerebrovascular disease: the benefits of early treatment (Q36249979) (← links)
- Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story (Q36475090) (← links)
- Pathology and pathogenesis of vascular cognitive impairment-a critical update (Q36754568) (← links)
- Therapeutic issues in vascular dementia: studies, designs and approaches (Q36808830) (← links)
- Difficulty with learning of exercise instructions associated with 'working memory' dysfunction and frontal glucose hypometabolism in a patient with very mild subcortical vascular dementia with knee osteoarthritis (Q37076831) (← links)
- Vascular cognitive impairment: current concepts and clinical developments (Q37085101) (← links)
- Age-associated leukoaraiosis and cortical cholinergic deafferentation (Q37180493) (← links)
- Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment (Q37225114) (← links)
- Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses (Q37245372) (← links)
- White matter tracts associated with set-shifting in healthy aging (Q37359726) (← links)
- Early-onset dementias: diagnostic and etiological considerations (Q37606162) (← links)
- Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia. (Q37644400) (← links)
- White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia (Q37667316) (← links)
- A review of transcranial magnetic stimulation in the in vivo functional evaluation of central cholinergic circuits in dementia (Q37912939) (← links)
- Drug therapy of post-stroke aphasia: a review of current evidence (Q37918433) (← links)
- Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. (Q38020618) (← links)
- Pathogenesis and treatment of vascular cognitive impairment (Q38297016) (← links)
- The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment. (Q38461735) (← links)
- Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation. (Q38738864) (← links)
- Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert. (Q38804275) (← links)
- Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. (Q40120849) (← links)
- Memory impairment in occipital periventricular hyperintensity patients is associated with reduced functional responses in the insula and Heschl's gyrus (Q40383531) (← links)
- Regional Gray Matter Atrophy Coexistent with Occipital Periventricular White Matter Hyper Intensities (Q41026944) (← links)
- Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial. (Q41281485) (← links)
- Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections (Q42222463) (← links)
- Loss of cholinergic pathways in vascular dementia of the Binswanger type. (Q42475931) (← links)
- Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study (Q45329106) (← links)
- Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease. (Q46091606) (← links)
- Is there a specific pattern of attention deficit in mild cognitive impairment with subcortical vascular features? Evidence from the Attention Network Test (Q46485838) (← links)
- Donepezil in vascular dementia: combined analysis of two large-scale clinical trials (Q46726995) (← links)
- Neural correlates of donepezil-induced cognitive improvement in patients with right hemisphere stroke: A pilot study (Q46839771) (← links)
- Vascular dementia and the cholinergic pathways (Q47131306) (← links)
- Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation. (Q47379319) (← links)
- Subinsular vascular lesions: an analysis of 119 consecutive autopsied brains (Q48310855) (← links)
- Association between white matter hyperintensity and lacunar infarction on MRI and subitem scores of the Japanese version of mini-mental state examination for testing cognitive decline: the Ohasama study. (Q48527810) (← links)
- Clinical characteristics in subcortical ischemic white matter disease. (Q48557748) (← links)
- Effects of trans-sylvian approach to basal forebrain projection fibers: verbal memory decline after selective amygdalohippocampectomy (Q49100459) (← links)
- Cholinesterase inhibitors in vascular cognitive impairment. (Q53341194) (← links)
- Subcortical hyperintensities in Alzheimer's disease: no clear relationship with executive function and frontal perfusion on SPECT. (Q53389298) (← links)